LLY vs ABBV
LLY and ABBV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | LLYELI LILLY AND COMPANY | ABBVAbbVie Inc. |
|---|---|---|
| Market cap | $1.07T | $464.74B |
| P/E (TTM) | 38.2 | 74.3 |
| P/B | 31.58 | — |
| P/S | 16.4x | 7.6x |
| Dividend yield | 0.50% | 2.51% |
| Revenue | $79.67B(TTM) | $61.16B(TTM) |
| Revenue growth (YoY) | 44.7% | 8.6% |
| Net income | $26.71B(TTM) | $6.31B(TTM) |
| Earnings growth (YoY) | 94.9% | -1.2% |
| EPS, diluted | $29.79(TTM) | $3.54(TTM) |
| EBIT margin | 40.2% | 24.6% |
| ROE | 60.9% | — |
| ROIC | 26.3% | 18.6% |
| 1y total return | +52.7% | +23.8% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: LLY vs ABBV
| Metric | LLY | ABBV |
|---|---|---|
| End value | $176.0K | $64.0K |
| Total return | +1660.0% | +540.2% |
| CAGR | +31.9% | +19.7% |
| Volatility | 30.1% | 25.9% |
| Sharpe | 0.94 | 0.67 |
| Sortino | 1.45 | 0.93 |
| Max drawdown | -34.5% | -45.1% |
Based on 2600 common trading days, 2016-05-12 → 2026-09-15 · risk-free 4.11% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)